Desonide
- Level
- Commodity
- Parent
- 51422300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51422304This classification denotes a therapeutic glucocorticoid with the molecular formula C24H32O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J280872D1O, chemically known as 16-alpha-hydroxyprednisole-16,17-acetonide but generally known as desonide, which bears US NIH Compound Identifier 12536. European Medicines Agency schedules Desonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07005MIG. The term DESONIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules desonide in its Anatomical Therapeutic Chemical (ATC) Classification. DESONIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule desonide under HS 29372900 and SITC 54153. As of Q4 2014, DESONIDE remains the US FDA Preferred Term for this commodity. Desonide bears US NLM identifiers UMLS ID C0011705 and NCI Concept Code C61702. SMILES: O1C2(C3(C(C4C(C(O)C3)C3(C(=CC(=O)C=C3)CC4)C)CC2OC1(C)C)C)C(=O)CO.
Same parent
Under 51422300 · 70Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.